Funds holding Luoxin Pharmaceuticals Group Stock Co Ltd
ISIN CNE1000026S7 · China
- Fund holders
- 6
- Of which ETFs
- 2 4 other funds
- Value held
- 2M $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND VANGUARD STAR FUNDS | 1,325,601 | 907.3K $ | 0.00 % | as of Jul 31, 2026 ↗ |
| VANGUARD EMERGING MARKETS STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 1,171,610 | 801.9K $ | 0.00 % | as of Jul 31, 2026 ↗ |
| VANGUARD FTSE ALL-WORLD EX-US SMALL-CAP INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 196,700 | 134.6K $ | 0.00 % | as of Jul 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF SPDR INDEX SHARES FUNDS | 193,100 | 109.2K $ | 0.01 % | as of Jun 30, 2026 ↗ |
| VANGUARD TOTAL WORLD STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 46,318 | 31.7K $ | as of Jul 31, 2026 ↗ | |
| VANGUARD ESG INTERNATIONAL STOCK ETF VANGUARD WORLD FUND | 15,800 | 10K $ | 0.00 % | as of May 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF SPDR INDEX SHARES FUNDS | 0.01 % | as of Jun 30, 2026 ↗ |
| VANGUARD FTSE ALL-WORLD EX-US SMALL-CAP INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 0.00 % | as of Jul 31, 2026 ↗ |
| VANGUARD EMERGING MARKETS STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 0.00 % | as of Jul 31, 2026 ↗ |
| VANGUARD ESG INTERNATIONAL STOCK ETF VANGUARD WORLD FUND | 0.00 % | as of May 31, 2026 ↗ |
| VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND VANGUARD STAR FUNDS | 0.00 % | as of Jul 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 6 | -3 | 2,949,129 | -5.5 % |
| 2026Q2 | 9 | -1 | 3,121,826 | -7.7 % |
| 2026Q1 | 10 | 0 | 3,381,326 | +1.2 % |
| 2025Q4 | 10 | 0 | 3,340,226 | -1.4 % |
| 2025Q3 | 10 | -4 | 3,386,226 | -13.2 % |
| 2025Q2 | 14 | 0 | 3,901,926 | -2.3 % |
| 2025Q1 | 14 | 0 | 3,994,326 | -1.5 % |
| 2024Q4 | 14 | +1 | 4,054,126 | +4.9 % |
| 2024Q3 | 13 | -1 | 3,863,426 | -6.1 % |
| 2024Q2 | 14 | +4 | 4,113,126 | +292.3 % |
| 2024Q1 | 10 | -4 | 1,048,597 | -72.8 % |
| 2023Q4 | 14 | 3,862,126 |
Cite this page
Titelia. "Funds holding Luoxin Pharmaceuticals Group Stock Co Ltd". https://titelia.com/en/stocks/luoxin-pharmaceuticals-group-stock-co-ltd-CNE1000026S7